Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McGill University
$105,000.00
Whole Genome Sequencing to identify novel loci in French Canadian ALS patients
EF 2017-18
Résumé
Despite over a decade of gene discovery, the genetic causes of Amyotrophic Lateral Sclerosis (also known as Lou Gehrig's disease or ALS) are not fully understood. Examining the sequence of human genes has opened many avenues of clinical research, and several genes are now known to be mutated in patients with ALS. However, the discovery rate of ALS-associated genes has not kept pace with predictions, and it is necessary to increase the scale of genetic studies. Most research has only examined small portions of the genome to look for mutations that cause ALS. Our study will use whole-genome sequencing to investigate all the DNA within a patient.
We propose to sequence the entire genome of 265 French-Canadian ALS patients to discover new disease-associated mutations. Because the disease is rare, and because mutations that cause the disease occur at very low frequencies in a population, we will employ recent statistical techniques that group mutations together to increase the power to detect associations. We will also be able to find regions of the genome that contain overly-repetitive or missing sections, which may alter the function of a gene and predispose one to develop ALS.
The French-Canadian patient group we will study is ideal for genetic discovery in ALS because it contains a single ethnicity in few geographic regions. This study group will help to minimize errors such as inherently distinct genetic backgrounds across different ethnicities, and various predisposing environmental factors.
The treatment and prevention of ALS will ultimately depend on a complete understanding of the processes and susceptibilities to the disease, and this understanding will start with the complete characterization of the genome when one has the disease. By knowing which mutations will result in ALS, we can try to predict the disease before it begins.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
387259
Name
Ross Jay
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Whole Genome Sequencing to identify novel loci in French Canadian ALS patients
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Amyotrophic Lateral Sclerosis; Bioinformatics; Genetic Association; High-Throughput; Molecular Biology; Mutation; Neurodegeneration; Population Stratification; Variant Burden; Whole Genome Sequencing
Abstract
Despite over a decade of gene discovery, the genetic causes of Amyotrophic Lateral Sclerosis (also known as Lou Gehrig's disease or ALS) are not fully understood. Examining the sequence of human genes has opened many avenues of clinical research, and several genes are now known to be mutated in patients with ALS. However, the discovery rate of ALS-associated genes has not kept pace with predictions, and it is necessary to increase the scale of genetic studies. Most research has only examined small portions of the genome to look for mutations that cause ALS. Our study will use whole-genome sequencing to investigate all the DNA within a patient.
We propose to sequence the entire genome of 265 French-Canadian ALS patients to discover new disease-associated mutations. Because the disease is rare, and because mutations that cause the disease occur at very low frequencies in a population, we will employ recent statistical techniques that group mutations together to increase the power to detect associations. We will also be able to find regions of the genome that contain overly-repetitive or missing sections, which may alter the function of a gene and predispose one to develop ALS.
The French-Canadian patient group we will study is ideal for genetic discovery in ALS because it contains a single ethnicity in few geographic regions. This study group will help to minimize errors such as inherently distinct genetic backgrounds across different ethnicities, and various predisposing environmental factors.
The treatment and prevention of ALS will ultimately depend on a complete understanding of the processes and susceptibilities to the disease, and this understanding will start with the complete characterization of the genome when one has the disease. By knowing which mutations will result in ALS, we can try to predict the disease before it begins.
Competitiondate
201710
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ross, Jay
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~